IgA-producing B cells in lung homeostasis and disease

Front Immunol. 2023 Mar 1:14:1117749. doi: 10.3389/fimmu.2023.1117749. eCollection 2023.

Abstract

Immunoglobulin A (IgA) is the most abundant Ig in mucosae where it plays key roles in host defense against pathogens and in mucosal immunoregulation. Whereas intense research has established the different roles of secretory IgA in the gut, its function has been much less studied in the lung. This review will first summarize the state-of-the-art knowledge on the distribution and phenotype of IgA+ B cells in the human lung in both homeostasis and disease. Second, it will analyze the studies looking at cellular and molecular mechanisms of homing and priming of IgA+ B cells in the lung, notably following immunization. Lastly, published data on observations related to IgA and IgA+ B cells in lung and airway disease such as asthma, cystic fibrosis, idiopathic pulmonary fibrosis, or chronic rhinosinusitis, will be discussed. Collectively it provides the state-of-the-art of our current understanding of the biology of IgA-producing cells in the airways and identifies gaps that future research should address in order to improve mucosal protection against lung infections and chronic inflammatory diseases.

Keywords: IgA+ B cells; airway disease; lung B cells; lung mucosal immunity; upper airway immunity.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asthma*
  • Humans
  • Idiopathic Pulmonary Fibrosis*
  • Immunoglobulin A
  • Immunoglobulin A, Secretory
  • Lung

Substances

  • Immunoglobulin A, Secretory
  • Immunoglobulin A

Grants and funding

AS is supported by an Aspirant fellowship of the Fonds National de la Recherche Scientifique, Belgium. (FRC), Brussels, Belgium. CP is postdoctoral specialist of the FNRS (grant 1.R016.20), Belgium. VH is supported by clinicien-chercheur mandates of (grant FNRS 1R20221F), Belgium.